12 Month Price Forecast For MASI
Distance to MASI Price Forecasts
MASI Price Momentum
🤔 Considering Masimo (MASI)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: January 23, 2025 10:03 AM UTC
MASI Analyst Ratings & Price Targets
Based on our analysis of 12 Wall Street analysts, MASI has a consensus that is bullish. The median price target is $190.00, with forecasts ranging from $155.10 to $210.00. Currently, there are 6 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
With MASI currently trading at $173.16, the median price forecast suggests a 9.7% upside. The most optimistic forecast comes from Jason Bednar at Piper Sandler, projecting a 21.3% upside, while at provides the most conservative target, suggesting a -10.4% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MASI Analyst Consensus
MASI Price Target Range
Latest MASI Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MASI.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 22, 2025 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Jan 16, 2025 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Dec 27, 2024 | Raymond James | Jayson Bedford | Outperform | Maintains | $194.00 |
| Dec 18, 2024 | Piper Sandler | Jason Bednar | Overweight | Maintains | $210.00 |
| Dec 11, 2024 | Wells Fargo | Vik Chopra | Overweight | Maintains | $193.00 |
| Nov 22, 2024 | Stifel | Rick Wise | Buy | Reiterates | $190.00 |
| Nov 6, 2024 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Nov 6, 2024 | Wells Fargo | Vik Chopra | Overweight | Maintains | $171.00 |
| Nov 6, 2024 | Raymond James | Jayson Bedford | Outperform | Upgrade | $170.00 |
| Nov 6, 2024 | Piper Sandler | Jason Bednar | Overweight | Maintains | $180.00 |
| Oct 14, 2024 | BTIG | Marie Thibault | Buy | Maintains | $170.00 |
| Sep 25, 2024 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Sep 20, 2024 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Aug 7, 2024 | Piper Sandler | Jason Bednar | Overweight | Maintains | $165.00 |
| Aug 7, 2024 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Jul 9, 2024 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Jun 3, 2024 | Piper Sandler | Jason Bednar | Overweight | Upgrade | $160.00 |
| May 8, 2024 | Piper Sandler | Jason Bednar | Neutral | Maintains | $126.00 |
| May 8, 2024 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Apr 15, 2024 | Stifel | Rick Wise | Buy | Upgrade | $170.00 |
Stocks Similar to Masimo Corp
The following stocks are similar to Masimo based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Masimo Corp (MASI) Financial Data
Masimo Corp has a market capitalization of $9.43B with a P/E ratio of 122.3x. The company generates $2.04B in trailing twelve-month revenue with a 3.8% profit margin.
Revenue growth is +5.4% quarter-over-quarter, while maintaining an operating margin of +6.0% and return on equity of +5.7%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Masimo Corp (MASI) Company Overview
About Masimo Corp
Develops advanced patient monitoring technologies.
The company generates revenue through the development, manufacturing, and marketing of a wide range of patient monitoring technologies and solutions. It sells products directly to hospitals, emergency services, and home care providers, as well as through e-commerce channels for home wellness products.
Masimo Corporation offers innovative technologies like pulse oximetry and brain function monitoring, addressing limitations in conventional methods. It has a diverse product lineup, including solutions for neuromodulation and telehealth, and has been operational since 1989, with its headquarters in Irvine, California.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
3,800
CEO
Ms. Michelle M. Brennan
Country
United States
IPO Year
2007
Website
www.masimo.comMasimo Corp (MASI) Latest News & Analysis
Masimo appointed Katie Szyman as CEO, succeeding founder Joe Kiani, following a proxy battle with Politan Capital Management.
Leadership changes can impact company strategy and performance. Katie Szyman's appointment may signal a shift in direction for Masimo, influencing investor sentiment and stock performance.
Masimo Taps Katie Szyman as Permanent CEO
2 days agoSzyman is the worldwide president of Advanced Patient Monitoring at Becton Dickinson and Co., a key leadership position within the company.
Szyman's leadership at Becton Dickinson in Advanced Patient Monitoring could signal strategic innovations, impacting the company's market position and growth potential in healthcare technology.
MASI's fourth-quarter revenue growth is expected to benefit from strong ongoing adoption of its products.
MASI's revenue growth signals strong product demand, indicating potential profitability and market strength, which can positively influence stock performance and investor confidence.
Masimo Announces Leadership Transition
2 days agoMasimo's Board appointed Katie Szyman as CEO, effective February 12, 2025. Michelle Brennan becomes Chairman, and Quentin Koffey is Vice Chairman. Szyman is currently worldwide president.
Leadership changes can significantly impact company strategy and performance, influencing investor confidence and stock prices. New CEO appointments often signal shifts in company direction.
Masimo Corporation (Nasdaq: MASI) reported preliminary Q4 2024 revenue of ~$601 million, up 9%. Healthcare revenue is estimated at ~$368 million. 2025 guidance provided.
Masimo's strong preliminary revenue growth and optimistic 2025 guidance signal robust demand and market confidence, influencing stock performance and investment decisions.
Senzime Reaches Second Milestone of Masimo Collaboration with Launch of Integration to Iris Gateway
10 days agoSenzime AB has achieved a second milestone in its collaboration with Masimo by integrating with the Masimo Iris® Gateway, enhancing its precision patient monitoring capabilities.
Senzime's collaboration with Masimo enhances its technology, potentially driving revenue growth and market competitiveness, which can positively influence stock performance and investor sentiment.
Frequently Asked Questions About MASI Stock
What is Masimo Corp's (MASI) stock forecast for 2025?
Based on our analysis of 12 Wall Street analysts, Masimo Corp (MASI) has a median price target of $190.00. The highest price target is $210.00 and the lowest is $155.10.
Is MASI stock a good investment in 2025?
According to current analyst ratings, MASI has 6 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $173.16. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for MASI stock?
Wall Street analysts predict MASI stock could reach $190.00 in the next 12 months. This represents a 9.7% increase from the current price of $173.16. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Masimo Corp's business model?
The company generates revenue through the development, manufacturing, and marketing of a wide range of patient monitoring technologies and solutions. It sells products directly to hospitals, emergency services, and home care providers, as well as through e-commerce channels for home wellness products.
What is the highest forecasted price for MASI Masimo Corp?
The highest price target for MASI is $210.00 from Jason Bednar at Piper Sandler, which represents a 21.3% increase from the current price of $173.16.
What is the lowest forecasted price for MASI Masimo Corp?
The lowest price target for MASI is $155.10 from at , which represents a -10.4% decrease from the current price of $173.16.
What is the overall MASI consensus from analysts for Masimo Corp?
The overall analyst consensus for MASI is bullish. Out of 12 Wall Street analysts, 6 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $190.00.
How accurate are MASI stock price projections?
Stock price projections, including those for Masimo Corp, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
